Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GenePOC

GenePOC
2007 FOUNDED
M&A STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
$120M LATEST DEAL AMOUNT
Description

Developer of a molecular diagnostics testing device designed to speed up the diagnostic process. The company's device is a portable instrument for the prevention and early detection of infectious diseases based on unique centripetal technology services, enabling healthcare professionals and patients to get affordable, simple, and rapid Point of Care (POC) molecular diagnostic tests for infectious diseases.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Parent Company
Primary Office
  • 360 rue Franquet, porte 3
  • Québec, Quebec G1P 4N3
  • Canada

+1 (418) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GenePOC’s full profile, request a free trial.

GenePOC Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Jun-2019 $120M 00000 Completed Generating Revenue
2. Merger/Acquisition 30-Aug-2016 Completed Generating Revenue
1. Later Stage VC 13-Jan-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

GenePOC Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
STAT-Dx Formerly VC-backed Barcelona, Spain 000.00 000000&0 000.00
0000000 0000000 00 Formerly VC-backed Yokneam Ilit, Israel 000.00 0000000000
00000000 Venture Capital-Backed Redwood City, CA 00 000.00 00000000000 000.00
000000 Corporation San Diego, CA 0000
0000000000000 Venture Capital-Backed Leuven, Belgium 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

GenePOC Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CM-CIC Investissement Growth/Expansion Minority 000 0000 000000 0
Debiopharm Group Corporation Majority 000 0000 000000 0
Emerillon Capital Venture Capital Minority 000 0000 000000 0

GenePOC Executive Team (9)

Name Title Board
Seat
Contact
Info
Patrice Allibert Ph.D Chief Executive Officer
Michel Bergeron Ph.D Co-Founder
Marie-Josée Paré Vice President of Finance & Administration
Jean Côté Vice President of Manufacturing
Dany Leblanc Vice President of Quality Assuranc, Regulatory Affairs & Clinical Operations

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

GenePOC Board Members (8)

Name Representing Role Since Contact
Info
Chuck Morrison GenePOC Board Member 000 0000
Denis Robichon Ph.D GenePOC Board Member 000 0000
Jeremy Bridge-Cook Ph.D Self Board Member 000 0000
Tanja Dowe Self Chairman 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »